Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Targeting neutrophil serine proteases in bronchiectasis.
The European respiratory journal·2024
Same author
Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.
The European respiratory journal·2024
Related Experiment Video
Updated: Jun 29, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Summary
Bronchiectasis is increasingly recognized globally, characterized by chronic cough and sputum. Early diagnosis via CT scans and tailored, multimodal treatment are crucial for managing this heterogeneous lung disease.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Bronchiectasis is increasingly diagnosed worldwide, affecting diverse populations.
- Characterized by chronic cough, sputum production, and recurrent bacterial infections leading to lung function decline.
- Prevalence is highest in older women, with diagnosis confirmed by high-resolution CT scans.
Purpose of the Study:
- To provide an overview of bronchiectasis, including its epidemiology, diagnosis, and management.
- To highlight the heterogeneous nature of the disease and the need for individualized treatment approaches.
Main Methods:
- Review of current understanding and clinical practices related to bronchiectasis.
- Emphasis on diagnostic tools like high-resolution CT scans.
- Discussion of multimodality treatment strategies.
Main Results:
- Bronchiectasis can be focal or diffuse, occurring with or without prior lung disease.
- Underlying causes include congenital conditions, immune disorders, or inflammatory diseases.
- Multimodality treatment involves antibiotics, anti-inflammatory agents, and airway clearance.
Conclusions:
- Bronchiectasis management requires a tailored, patient-focused approach due to its variable prognosis.
- Resectional surgery and lung transplantation are rarely indicated.
- Optimal evaluation and treatment are essential for individuals with bronchiectasis.